CCR2 inhibition sequesters multiple subsets of leukocytes in the bone marrow

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Fujimura, Naoki ^a,b   Xu, Baohui ^a   Dalman, Jackson ^a   Deng, Hongping ^a   Aoyama, Kohji ^c   Dalman, Ronald L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAISEIKAI CENTRAL HOSPITAL   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYETHYLGERMANIUM SESQUIOXIDE; CCR2 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR2; ORGANOMETALLIC COMPOUND;

ANIMAL; ANTAGONISTS AND INHIBITORS; BONE MARROW CELL; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; LEUKOCYTE; METABOLISM; MOUSE; TRANSGENIC MOUSE;

ANIMALS; BONE MARROW CELLS; GENE EXPRESSION REGULATION; LEUKOCYTES; MICE; MICE, TRANSGENIC; ORGANOMETALLIC COMPOUNDS; RECEPTORS, CCR2;

EID: 84937922196     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11664     Document Type: Article

References (54)

1. Butcher, E. C., Picker, L. J. Lymphocyte homing and homeostasis. Science 272, 60-66 (1996).
2. Cyster, J. G. Chemokines and cell migration in secondary lymphoid organs. Science 286, 2098-2102 (1999).
3. Xu, B. et al. Lymphocyte homing to bronchus-associated lymphoid tissue (BALT) is mediated by L-selectin/PNAd, alpha4beta1 integrin/VCAM-1, and LFA-1 adhesion pathways. J. Exp. Med. 197, 1255-1267 (2003).
4. Xu, B., Cook, R. E., Michie, S. A. Alpha4beta7 integrin/MAdCAM-1 adhesion pathway is crucial for B cell migration into pancreatic lymph nodes in nonobese diabetic mice. J. Autoimmun. 35, 124-129 (2010).
5. Mikulowska-Mennis, A., Xu, B., Berberian, J. M., Michie, S. A. Lymphocyte migration to inflamed lacrimal glands is mediated by vascular cell adhesion molecule-1/alpha(4)beta(1) integrin, peripheral node addressin/l-selectin, and lymphocyte functionassociated antigen-1 adhesion pathways. Am. J. Pathol. 159, 671-681 (2001).
6. Wagner, N. et al. Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue. Nature 382, 366-370 (1996).
7. Shan, Z., Xu, B., Mikulowska-Mennis, A., Michie, S. A. CCR7 directs the recruitment of T cells into inflamed pancreatic islets of nonobese diabetic (NOD) mice. Immunol. Res. 58, 351-357 (2014).
8. Bromley, S. K., Thomas, S. Y., Luster, A. D. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol. 6, 895-901 (2005).
9. Debes, G. F. et al. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat Immunol. 6, 889-894 (2005).
10. Geissmann, F., Jung, S., Littman, D. R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82 (2003).
11. Deshmane, S. L., Kremlev, S., Amini, S., Sawaya, B. E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon. Cytokine. Res. 29, 313-326 (2009).
12. Zlotnik, A., Yoshie, O. The chemokine superfamily revisited. Immunity 36, 705-716 (2012).
13. Mack, M. et al. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166, 4697-4704 (2001).
14. Imhof, B. A., Aurrand-Lions, M. Adhesion mechanisms regulating the migration of monocytes. Nat Rev. Immunol. 4, 432-444 (2004).
15. Serbina, N. V. and Pamer, E. G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol. 7, 311-317 (2006)
16. Tsou, C. L. et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117, 902-909 (2007).
17. Engel, D. R. et al. CCR2 mediates homeostatic and inflammatory release of Gr1(high) monocytes from the bone marrow, but is dispensable for bladder infiltration in bacterial urinary tract infection. J. Immunol. 181, 5579-5586 (2008).
18. Shi, C. et al. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating tolllike receptor ligands. Immunity 34, 590-601 (2011).
19. Swirski, F. K. et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117, 195-205 (2007).
20. Hirayama, C., Suzuki, H., Ito, M., Okumura, M., Oda, T. Propagermanium: a nonspecific immune modulator for chronic hepatitis B. J. Gastroenterol. 38, 525-532 (2003).
21. Yokochi, S. et al. An anti-inflammatory drug, propagermanium, may target GPI-anchored proteins associated with an MCP-1 receptor, CCR2. J. Interferon. Cytokine. Res. 21, 389-398 (2001).
22. Gliem, M. et al. Macrophages prevent hemorrhagic infarct transformation in murine stroke models. Ann. Neurol. 71, 743-752 (2012).
23. Tamura, Y. et al. Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice. Arterioscler. Thromb. Vasc. Biol. 28, 2195-2201 (2008).
24. Kitagawa, K. et al. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am. J. Pathol. 165, 237-246 (2004).
25. Shimokawa, H. et al. Propagermanium suppresses macrophage-mediated formation of coronary arteriosclerotic lesions in pigs in vivo. J. Cardiovasc. Pharmacol. 41, 372-380 (2003).
26. Furuichi, K. et al. CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J. Am. Soc. Nephrol. 14, 2503-2515 (2003).
27. Yamashita, T. et al. Propagermanium reduces atherosclerosis in apolipoprotein E knockout mice via inhibition of macrophage infiltration. Arterioscler. Thromb. Vasc. Biol. 22, 969-974 (2002).
28. Saederup, N. et al. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PloS One 5, e13693 (2010).
29. Ford, L. B. et al. Characterization of conventional and atypical receptors for the chemokine CCL2 on mouse leukocytes. J. Immunol. 193, 400-411 (2014).
30. Sawai, C. M. et al. Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells. J. Exp. Med. 210, 2151-2159 (2013).
31. Bruhl, H. et al. Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases. Clin. Exp. Immunol. 126, 551-559 (2001).
32. Flaishon, L. et al. Expression of the chemokine receptor CCR2 on immature B cells negatively regulates their cytoskeletal rearrangement and migration. Blood 104, 933-941 (2004).
33. Reichel, C. A. et al. Chemokine receptors Ccr1, Ccr2, and Ccr5 mediate neutrophil migration to postischemic tissue. J. Leukoc. Biol. 79, 114-122 (2006).
34. Maus, U. A. et al. Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis. J. Immunol. 170, 3273-3278 (2003).
35. Hartl, D. et al. Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. J. Immunol. 181, 8053-8067 (2008).
36. Souto, F. O. et al. Essential role of CCR2 in neutrophil tissue infiltration and multiple organ dysfunction in sepsis. Am. J. Respir. Crit. Care. Med. 183, 234-242 (2011).
37. Maus, U. et al. The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice. Am. J. Respir. Crit. Care. Med. 166, 268-273 (2002).
38. Mercer, P. F. et al. Proteinase-activated receptor-1, CCL2, and CCL7 regulate acute neutrophilic lung inflammation. Am. J. Respir. Cell. Mol. Biol. 50, 144-157 (2014).
39. Speyer, C. L. et al. Novel chemokine responsiveness and mobilization of neutrophils during sepsis. Am. J. Pathol. 165, 2187-2196 (2004).
40. Iida, S., Kohro, T., Kodama, T., Nagata, S., Fukunaga, R. Identification of CCR2, flotillin, and gp49B genes as new G-CSF targets during neutrophilic differentiation. J. Leukoc. Biol. 78, 481-490 (2005).
41. Ma, Q., Jones, D., Springer, T. A. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 10, 463-471 (1999).
42. Allende, M. L. et al. S1P1 receptor directs the release of immature B cells from bone marrow into blood. J. Exp. Med. 207, 1113-1124 (2010).
43. Jenne, C. N. et al. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J. Exp. Med. 206, 2469-2481 (2009).
44. Nie, Y. et al. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J. Exp. Med. 200, 1145-1156 (2004).
45. Walzer, T. et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol. 8, 1337-1344 (2007).
46. Pereira, J. P., Xu, Y., Cyster, J. G. A role for S1P and S1P1 in immature-B cell egress from mouse bone marrow. PloS One 5, e9277 (2010).
47. van Helden, M. J., Zaiss, D. M., Sijts, A. J. CCR2 defines a distinct population of NK cells and mediates their migration during influenza virus infection in mice. PloS One 7, e52027 (2012).
48. Liu, Q., Smith, C. W., Zhang, W., Burns, A. R., Li, Z. NK cells modulate the inflammatory response to corneal epithelial abrasion and thereby support wound healing. Am. J. Pathol. 181, 452-462 (2012).
49. Zhao, E. et al. Bone marrow and the control of immunity. Cell. Mol. Immunol. 9, 11-19 (2012).
50. Fujii, T. et al. FTY720 suppresses the development of colitis in lymphoid-null mice by modulating the trafficking of colitogenic CD4+ T cells in bone marrow. Eur. J. Immunol. 38, 3290-3303 (2008).
51. Maeda, Y., Seki, N., Sato, N., Sugahara, K., Chiba, K. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow. Int. Immunol. 22, 515-525 (2010).
52. Allende, M. L. et al. S1P1 receptor expression regulates emergence of NKT cells in peripheral tissues. FASEB J. 22, 307-315 (2008).
53. Swirski, F. K. et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325, 612-616 (2009).
54. Kaplan, B. J., Parish, W. W., Andrus, G. M., Simpson, J. S., Field, C. J. Germane facts about germanium sesquioxide: I. Chemistry and anticancer properties. J. Altern. Complement. Med. 10, 337-344 (2004).